Silo Pharma, Inc.

US$1.33As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:SILOHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (91.23%)
Biotechnology
Beta (5Y) 0.91
PE TTM —
TSR TTM (83.63%)
Mkt cap US$2.112M
ROIC (56.89%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.29
(3.01%)
(25.51%)
Buy 9|2|1|1|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
12.49%
18.86%
27.31%
17.87%
Revenue$M
0.217
0.219
0.229
0.233
0.75%
0.92%
8.00%
7.48%
Peers (US$2.112M)
Cap (US$)
PE
2.281M
—
Capital
TTM
5Y
10Y
Leveragex
0.424
0.088
0.084
EBIT/Intx
1.371
1.188
1.049
Own earn%
(98.95)
(71.15)
(48.04)
Sh yield%
32.96
41.13
44.19
Owners
Insiders/Inst%
11.80
77.02
Short interest%
2.69
SBC / revenue%
5.54
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
0
Op margin range%
20–24
$1 testx
—
Incr. ROIC%
4